Strengthening Physician Communication About HPV Vaccines

Not Applicable

Completed

• Conditions: HPV Immunization Status
• Interventions: Behavioral: Multimodal Vaccine Program

• Registration Number: NCT02456077
• Lead Sponsor: University of Colorado, Denver

Brief Summary

The purpose of this study is to determine if a multimodal Human Papillomavirus (HPV) immunization program carried out in pediatric and family medicine practices would be more effective in improving adolescent patients' HPV immunization rates than the usual care provided to adolescents in pediatric and family medicine practices.

Detailed Description

Not available

Study Timeline

• Study Start: 2015-02-01
• Study First Submitted: 2015-05-26
• Study First Submitted QC: 2015-05-27
• Study First Posted: 2015-05-28
• Primary Completion: 2016-01-31
• Study Completion: 2016-01-31
• Status Verified: 2019-06
• Last Update Submitted: 2019-06-21
• Last Update Posted: 2019-06-24

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 93582

Inclusion Criteria

Not provided

Exclusion Criteria

1. Less than 9 years of age when presenting for care
2. Patient is not eligible for HPV immunization

Provider survey:

Providers who are working at participating practices during the two times a cross-sectional survey is administered.

Parent survey:

Parents of adolescents who presented for care within one 1 year prior to the two times a cross-sectional survey is administration.

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Intervention Practices	Multimodal Vaccine Program	Intervention offices will adopt a multi-modal vaccine program to increase their patients' vaccine rates.

Primary Outcome Measures

Name	Time	Method
The percentage of adolescents who initiate the HPV vaccine series	1 year	The percent of eligible patients presenting for care at intervention offices who receive one or more HPV vaccines (using administrative, Electronic Medical Records (EMR), and Colorado Immunization Information System (CIIS) immunization data), during the intervention year, compared to the percent in control offices.

Secondary Outcome Measures

Name	Time	Method
Provider HPV vaccine recommendations	1 year	The change in intervention providers' HPV vaccine communication practices compared to control providers' as measured by self-report prior to the intervention and after the intervention.
Parents' experiences and preferences regarding provider communication about HPV vaccines	1 year	The change in intervention parents' experiences and preferences regarding provider HPV vaccine communication compared to parents of adolescents attending control practices as measured by self report prior to the intervention and after the intervention.
The percentage of adolescents who receive MCV4 vaccine	1 year	The percent of eligible patients presenting for care at intervention offices who receive MCV4 vaccine (using administrative, EMR and CIIS immunization data) compared to the percent in control offices.
The percentage of adolescents who receive Tdap vaccine	1 year	The percentage of eligible patients presenting for care at intervention offices who receive Tetanus, Diphtheria, Pertussis (Tdap) vaccine (using administrative, EMR and CIIS immunization data) during the intervention year compared to the percent in control offices.

Trial Locations

Locations (1)

University of Colorado Denver; 🇺🇸 Aurora, Colorado, United States